Trade AbbVie ^ABBV

AbbVie Delivers Strong Q1 Earnings Beyond Humira. This Dividend King Still Shines.

How Investors Are Reacting To AbbVie (ABBV) Leaning On Immunology After Q1 Profit Decline

Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance | Morningstar

AbbVie Inc. (NYSE:ABBV) Receives $252.90 Consensus Price Target from Analysts

Gateway Investment Advisers LLC Buys 4,229 Shares of AbbVie Inc. $ABBV

Sequoia Financial Advisors LLC Raises Stock Holdings in AbbVie Inc. $ABBV - Daily Political

Ponta Wealth Partners LLC Makes New Investment in AbbVie Inc. $ABBV - Daily Political

Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? - AOL

Pharmaceutical Stocks Worth Watching - May 6th - Stock Observer

6 Pharma Dividend Stocks Yielding Up to 6.44% - and They've Survived Every Market Crash

3,097 Shares in AbbVie Inc. $ABBV Purchased by Providence First Trust Co - Zolmax

Indivisible Partners Invests $2.19 Million in AbbVie Inc. $ABBV

AbbVie Expands SKYRIZI Access As Immunology And Dividend Story Evolves

Avalo's phase 2 skin disease win fuels pursuit of AbbVie despite placebo headwind

AbbVie Inc. $ABBV Position Reduced by Bokf Na

Sumitomo Mitsui DS Asset Management Company Ltd Has $72.32 Million Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. $ABBV Holdings Boosted by Mitsubishi UFJ Asset Management Co. Ltd. - Daily Political

Bokf Na Has $50.44 Million Stock Position in AbbVie Inc. $ABBV - Stock Observer

Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality

AbbVie Inc. $ABBV Shares Acquired by QRG Capital Management Inc.

ABBV Maintained by Evercore ISI Group -- Price Target Raised to $236

10 Years, Zero Regrets: The Dividend Stocks I Keep Buying

Truist Financial Corp Grows Position in AbbVie Inc. $ABBV

Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS) | Morningstar

SKYRIZI® (risankizumab) Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis

SKYRIZI® Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis | INN

AbbVie Inc. $ABBV Shares Sold by PKO Investment Management Joint Stock Co

5,538 Shares in AbbVie Inc. $ABBV Acquired by Legacy Edge Advisors LLC

Assessing AbbVie (ABBV) Valuation After Raised Guidance And Strong Q1 Growth Drivers

AbbVie (NYSE:ABBV) Given Buy Rating at Guggenheim - Stock Observer

Robertson Stephens Wealth Management LLC Boosts Holdings in AbbVie Inc. $ABBV - Stock Observer

PFA Pension Forsikringsaktieselskab Invests $242.03 Million in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Upgraded to "Strong-Buy" at DZ Bank - Daily Political

AbbVie Inc. (NYSE:ABBV) Given Average Rating of "Moderate Buy" by Brokerages

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries

AbbVie (NYSE:ABBV) Updates Q2 2026 Earnings Guidance

AbbVie (NYSE:ABBV) Trading Up 3.3% After Earnings Beat - Daily Political

ABBV Reiterated by Guggenheim -- Price Target Maintained at $249

AbbVie (NYSE:ABBV) Stock Price Down 2.2% - Here's What Happened - Stock Observer

Oppenheimer & Co. Inc. Sells 8,094 Shares of AbbVie Inc. $ABBV

Discover 3 Stocks That Might Be Trading Below Estimated Value

Fifth Third Bancorp Grows Stock Holdings in AbbVie Inc. $ABBV

Is AbbVie Inc. (ABBV) One of the Best Drug Stocks to Buy According to Analysts?

AbbVie Inc. $ABBV Shares Bought by Fifth Third Bancorp - Daily Political

New York State Teachers Retirement System Sells 39,154 Shares of AbbVie Inc. $ABBV - Zolmax

ABBV Maintained by Canaccord Genuity -- Price Target Raised to $265

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

Canaccord Genuity Group Issues Positive Forecast for AbbVie (NYSE:ABBV) Stock Price

Bank of America Upgrades AbbVie (ABBV) on Skyrizi Strength, Lifts PT

Top Medical Stocks To Consider - April 27th - Stock Observer

AbbVie (NYSE:ABBV) Shares Up 3.8% Following Analyst Upgrade

AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec | Taiwan News | May. 1, 2026 03:00

ABBV Maintained by Morgan Stanley -- Price Target Raised to $278

New York State Teachers Retirement System Reduces Stock Holdings in AbbVie Inc. $ABBV - Daily Political

AbbVie (NYSE:ABBV) Price Target Raised to $278.00

Best Dividend Stocks To Follow Today - April 30th - Stock Observer

AbbVie's (ABBV) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Research Analysts' Price Target Changes for April 30th (ABBV, ACGL, AER, AMP, AMZN, ARE, AVY, BAND, BELFB, BILL) - Stock Observer

Stock Analysts' Updated EPS Estimates for April 30th (ABBV, AIRJ, AMT, AMZN, APPN, BTU, CMG, CMRC, CSTM, DCC) - Stock Observer

AbbVie (NYSE:ABBV) Issues Quarterly Earnings Results - Daily Political

AbbVie Inc. $ABBV Shares Sold by State of New Jersey Common Pension Fund D

US Bancorp DE Sells 41,982 Shares of AbbVie Inc. $ABBV

AbbVie Inc. (NYSE:ABBV) Q1 2026 Earnings Call Transcript

Deoxycholic Acid Obesity Drugs Market Analysis Report 2026: $970 Mn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

AbbVie Exceeds Earnings Expectations with Surge in Skyrizi and Rinvoq Sales Amid Humira Decline, ETPharma

OSE Immunotherapeutics Reports Full Year 2025 Unaudited Consolidated Financial Results and 2026 Q1 Cash Position | Taiwan News | Apr. 30, 2026 13:30

Q1 2026 AbbVie Inc Earnings Call Transcript

AbbVie Q1 Earnings Call Highlights

AbbVie's patent on immunology therapy rejected

AbbVie (ABBV) Reports Strong Q1 2026 Results and Raises Full-Year Guidance

AbbVie (NYSE:ABBV) Trading 3.3% Higher - Time to Buy?

AbbVie Inc (ABBV) Shares Surge 3.1% -- What GF Score of 85 Tells

AbbVie (NYSE:ABBV) Posts Earnings Results, Misses Expectations By $0.36 EPS

ABBV Misses Q2 Revenue Expectations Slightly

Keybank National Association OH Raises Stake in AbbVie Inc. $ABBV - Daily Political

AbbVie raises outlook as blockbuster Skyrizi faces new rivals

AbbVie Raises 2026 Outlook To $14.28 As Q1 Earnings Beat Estimates

ABBV Shows Strong Fundamentals and Progress in Programs

AbbVie (ABBV) Raises Full-Year Earnings Outlook Following Q1 Revenue Beat

Top Dividend Stocks To Research - April 29th - Daily Political

Is AbbVie (ABBV) 1.6% Undervalued After Q1 2026? Adjusted EPS $2.65 Beats vs. $1. ...

AbbVie (ABBV) Reports Q1 Results with Revenue Beat and EPS Miss

AbbVie (ABBV) Stock Jumps on Strong Q1 Beat and Upgraded Full-Year Forecast

AbbVie Q1 Profit Down, Revenues Rise; Lifts FY26 Earnings View - Update

AbbVie Q1 26 Earnings Conference Call At 9:00 AM ET

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline

Keybank National Association OH Boosts Holdings in AbbVie Inc. $ABBV

AbbVie Seeks FDA Approval To Expand RINVOQ Use For Alopecia Areata

Federal judge strikes down North Dakota pharmaceutical law as unconstitutional

AbbVie (ABBV) Anticipates Strong Q1 Earnings and Robust Growth Drivers

AbbVie (ABBV) Reports Superior Efficacy of Rinvoq Over Humira in

AbbVie Inc. $ABBV Shares Sold by Vest Financial LLC

AbbVie Inc. $ABBV Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Warren Buffett's ETF Pick: Why the Vanguard S&P 500 ETF Remains a Smart Investment

AbbVie's Future: Growth Outlook and Key Challenges Ahead

AbbVie: A Reliable Dividend King for Long-Term Investors

AbbVie: A Dividend King and Pharmaceutical Bargain

Navigating an Overvalued Market: The Vanguard Value ETF as a Defensive Play

AI Podcast: Dollar Weakness and Investment Implications

HSBC: Three 'Painful Trade' Risks Loom if Wall Street Gets It Wrong

Zelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks

Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets

US Government Shutdown: Economic Fallout and Political Impasse

Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty

Global Market Overview: Precious Metals Surge Amidst Economic Uncertainty

Japan LDP-Ishin Policy Talks: Paving the Way for a New Prime Minister?

Israel Prepares to Reopen Rafah Crossing Amid Ceasefire Violation Claims

Fed's Rate Cut Conundrum: An Outlook to 2026